The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.
T. C. Gauler
No relevant relationships to disclose
C. Poettgen
No relevant relationships to disclose
H. Wagner
No relevant relationships to disclose
S. Korfee
No relevant relationships to disclose
R. Hepp
No relevant relationships to disclose
G. Stamatis
No relevant relationships to disclose
J. Von Pawel
No relevant relationships to disclose
B. Passlick
No relevant relationships to disclose
V. Budach
No relevant relationships to disclose
H. Wilke
No relevant relationships to disclose
S. Seeber
No relevant relationships to disclose
M. Stuschke
Research Funding - German Cancer Aid
W. E. E. Eberhardt
Research Funding - German Cancer Aid